ERD

Targeted pharmacological therapy restores β-cell function for diabetes remission

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

CNS-targeting pharmacological interventions for the metabolic syndrome

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Corrigendum to “Time-resolved hypothalamic open flow micro-perfusion reveals normal leptin transport across the blood�...

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Corrigendum to “Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice” [Molecu...

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Hypothalamic astrocytes control systemic glucose metabolism and energy balance

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to...

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Periodic Reporting for period 4 - HypoFlam (Targeting hypothalamic inflammation in obesity and diabetes)

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induce...

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension.

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Short-term cold exposure supports human Treg induction in vivo

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Functional identity of hypothalamic melanocortin neurons depends on Tbx3

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Chronic d-serine supplementation impairs insulin secretion

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

CNS-targeting pharmacological interventions for the metabolic syndrome

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Anti-Obesity Therapy: from Rainbow Pills to Polyagonists

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Peptide-based multi-agonists: a new paradigm in metabolic pharmacology

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogene...

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Endothelial HIF-1α Enables Hypothalamic Glucose Uptake to Drive POMC Neurons

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Dietary sugars, not lipids, drive hypothalamic inflammation

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Disruption of Lipid Uptake in Astroglia Exacerbates Diet-Induced Obesity

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

TNFα drives mitochondrial stress in POMC neurons in obesity

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Emerging Poly-Agonists for Obesity and Type 2 Diabetes

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Therapeutic Potential of Targeting the Ghrelin Pathway

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Are peptide conjugates the golden therapy against obesity?

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Ghrelin regulation of glucose metabolism

Project: HypoFlam

Updated at: 27-04-2024

Show more information

Project acronym HypoFlam

Resources

Selected filters:

Targeted pharmacological therapy restores β-cell function for diabetes remission

CNS-targeting pharmacological interventions for the metabolic syndrome

Corrigendum to “Time-resolved hypothalamic open flow micro-perfusion reveals normal leptin transport across the blood�...

Corrigendum to “Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice” [Molecu...

Hypothalamic astrocytes control systemic glucose metabolism and energy balance

Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice

Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to...

Periodic Reporting for period 4 - HypoFlam (Targeting hypothalamic inflammation in obesity and diabetes)

Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induce...

Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension.

The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling

Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability

Short-term cold exposure supports human Treg induction in vivo

Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism

GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice

Functional identity of hypothalamic melanocortin neurons depends on Tbx3

Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases

Chronic d-serine supplementation impairs insulin secretion

CNS-targeting pharmacological interventions for the metabolic syndrome

Anti-Obesity Therapy: from Rainbow Pills to Polyagonists

Peptide-based multi-agonists: a new paradigm in metabolic pharmacology

Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogene...

Endothelial HIF-1α Enables Hypothalamic Glucose Uptake to Drive POMC Neurons

Dietary sugars, not lipids, drive hypothalamic inflammation

Disruption of Lipid Uptake in Astroglia Exacerbates Diet-Induced Obesity

TNFα drives mitochondrial stress in POMC neurons in obesity

Emerging Poly-Agonists for Obesity and Type 2 Diabetes

Therapeutic Potential of Targeting the Ghrelin Pathway

Are peptide conjugates the golden therapy against obesity?

Ghrelin regulation of glucose metabolism